Stem Cells To Cure Sickle Cell Anemia
Harvard Medical Student Review · 2020
DOI: 10.65539/056mjw33 ↗Kurz gefasst
Fachartikel in der Zeitschrift Harvard Medical Student Review, 2020. Verfasst von Tolulope O. Rosanwo. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Sickle cell anemia (SCA) is one of the most prevalent genetic disorders in the world and the most common congenital anemia in the United States. The severity of SCA spans from mild clinical cases, managed by careful living, to severe cases involving bone crises, infection, stroke, and multi-organ failure. Hematopoietic stem cell transplantation (HSCT) is the most widely known and effective method to cure the disease and is used today in only severe cases due to risks of graft rejection and fatal infections. The use of stem cells for the cure of sickle cell disease from the early days of transplantation to the most recent breakthroughs in stem cell therapy, gene therapy and genome-editing will be examined in this review.
Zitieren
APA
Rosanwo, T. O. (2020). Stem Cells To Cure Sickle Cell Anemia. Harvard Medical Student Review. https://doi.org/10.65539/056mjw33
Vancouver
Rosanwo TO. Stem Cells To Cure Sickle Cell Anemia. Harvard Medical Student Review. 2020. doi:10.65539/056mjw33
BibTeX
@article{Rosanwo2020,
author = {Rosanwo, Tolulope O.},
title = {Stem Cells To Cure Sickle Cell Anemia},
journal = {Harvard Medical Student Review},
year = {2020},
doi = {10.65539/056mjw33}
}
EUVIMED